Peer-reviewedCC BY 4.0Communications Medicine
DExT for direct ex vivo drug testing
Related
- FDA Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites: Testing Presence, Prominence, and Wording
- Advancing the Translational Pipeline: From In Vivo and In Vitro 2D Models to Next-Generation Cell Culture Models for Amyotrophic Lateral Sclerosis Modelling and Drug Discovery
- Development and optimization of a prolonged-release drug delivery system of progesterone for enhancing conception rate: in vitro and in vivo evaluation
- The Effects of Continuous Venovenous Hemofiltration on Immunosuppressive Drug concentrations in an Ex‐Vivo Model of the critically Ill Adult: (CITRIC) study
- Performance of Direct Identification and EUCAST Rapid Antimicrobial Susceptibility Testing in Bloodstream Infections Using Sepsityper® and Disk Diffusion Methods
BibTeX
@article{lih2026dext,
title = {{DExT for direct ex vivo drug testing}},
author = {T. Mamie Lih and Lijun Chen and Hui Zhang},
journal = {Communications Medicine},
year = {2026},
month = nov,
doi = {10.1038/s43856-026-01981-0},
url = {https://www.nature.com/articles/s43856-026-01981-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - DExT for direct ex vivo drug testing
AU - T. Mamie Lih
AU - Lijun Chen
AU - Hui Zhang
PY - 2026
DA - 2026/11/05
JO - Communications Medicine
DO - 10.1038/s43856-026-01981-0
UR - https://www.nature.com/articles/s43856-026-01981-0
SN - 2730-664X
ER -